Log in | Register

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 19, Issue 9

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 19, Issue 9 (2020)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 19, Issue 9 (2020)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Volume 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Is the lack of evidence in older adults with cancer compromising safety?

Darryl Outlaw & Grant R. Williams

Pages: 1059-1061

Published online: 05 Aug 2020

AbstractforIs the lack of evidence in older adults with cancer compromising safety? | Full Text | References | PDF (253.1 KB) | EPUB

956 Views
8 CrossRef citations
0Altmetric

Free Access

Drug Evaluation

Article

Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidine

Saori Mishima, Akihito Kawazoe & Kohei Shitara

Pages: 1063-1068

Published online: 12 Aug 2020

AbstractforSafety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidine | Full Text | References | PDF (300.1 KB) | EPUB

181 Views
1 CrossRef citations
0Altmetric

Systematic Review

Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review

Huah Shin Ng, Constanza Luzon Rosenbult & Helen Tremlett

Pages: 1069-1094

Published online: 31 Aug 2020

1021 Views
22 CrossRef citations
0Altmetric

Review

The risk of cardiovascular complications with current obesity drugs

Ariana M. Chao, Thomas A. Wadden, Robert I. Berkowitz, Kerry Quigley & Frank Silvestry

Pages: 1095-1104

Published online: 09 Sep 2020

AbstractforThe risk of cardiovascular complications with current obesity drugs | Full Text | References | PDF (384.5 KB) | EPUB

552 Views
13 CrossRef citations
0Altmetric

Safety considerations with targeted therapy drugs for B-cell non-Hodgkin lymphoma

Shinichi Makita, Rika Hosoba & Kensei Tobinai

Pages: 1105-1120

Published online: 25 Aug 2020

AbstractforSafety considerations with targeted therapy drugs for B-cell non-Hodgkin lymphoma | Full Text | References | PDF (4.3 MB) | EPUB

638 Views
5 CrossRef citations
0Altmetric

Long-term drug treatment in multiple sclerosis: safety success and concerns

Dejan Jakimovski, Caila B Vaughn, Svetlana Eckert, Robert Zivadinov & Bianca Weinstock-Guttman

Pages: 1121-1142

Published online: 13 Aug 2020

AbstractforLong-term drug treatment in multiple sclerosis: safety success and concerns | Full Text | References | PDF (575.4 KB) | EPUB

576 Views
10 CrossRef citations
0Altmetric

Cardiovascular safety risks associated with gout treatments

Giovanna Rosas, Angelo Gaffo, Elizabeth J. Rahn & Kenneth G. Saag

Pages: 1143-1154

Published online: 12 Aug 2020

AbstractforCardiovascular safety risks associated with gout treatments | Full Text | References | PDF (1.9 MB) | EPUB

266 Views
2 CrossRef citations
0Altmetric

Safety considerations when using non-ergot dopamine agonists to treat Parkinson’s disease

Fabrizio Stocchi, Barbara Fossati & Margherita Torti

Pages: 1155-1172

Published online: 03 Oct 2020

AbstractforSafety considerations when using non-ergot dopamine agonists to treat Parkinson’s disease | Full Text | References | PDF (517.2 KB) | EPUB

304 Views
4 CrossRef citations
0Altmetric

Systematic review & meta-analysis

Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis

Vibhu Paudyal, Abdullah Al-Hamid, Matthew Bowen, Muhammad Abdul Hadi, Syed Shahzad Hasan, Zahraa Jalal & Derek Stewart

Pages: 1173-1191

Published online: 03 Oct 2020

420 Views
27 CrossRef citations
0Altmetric

Original research

Article

Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials

Hirotaka Watada, Toshimasa Yamauchi, Fumiko Yamamoto, Atsushi Taniguchi, Larisa Yarush, Clemens Heilmann & Atsutaka Yasui

Pages: 1193-1202

Published online: 02 Jul 2020

AbstractforSafety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials | Full Text | References | PDF (273.8 KB) | EPUB

1114 Views
7 CrossRef citations
0Altmetric

Article

The effects of atorvastatin and rosuvastatin on exercise tolerance in patients with coronary heart disease

Dan Liu, Tao Shen, Chuan Ren, Shunlin Xu, Lequn Zhou, Jin Bai, Nan Li, Wei Zhao & Wei Gao

Pages: 1203-1208

Published online: 02 Jul 2020

AbstractforThe effects of atorvastatin and rosuvastatin on exercise tolerance in patients with coronary heart disease | Full Text | References | PDF (578.1 KB) | EPUB

253 Views
2 CrossRef citations
0Altmetric

Article

Neonatal fluid and electrolytes profile effect on amphotericin B associated nephrotoxicity in neonatal tertiary care unit of Karachi-Pakistan

Gul Ambreen, Arshalooz Rehman, Kashif Hussain, Mehreen Sohail, Saba Javed, Syed Shamim, Umer Ali, Khalil Ahmad & Arjumand Rizvi

Pages: 1209-1217

Published online: 22 Jun 2020

AbstractforNeonatal fluid and electrolytes profile effect on amphotericin B associated nephrotoxicity in neonatal tertiary care unit of Karachi-Pakistan | Full Text | References | PDF (448.2 KB) | EPUB

158 Views
2 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Comparison of four criteria for potentially inappropriate medications in older patients with newly diagnosed non-small cell lung cancer

Man Xu et al.

Article | Published online: 22 May 2024

Adverse tumor events induced by ranitidine: an analysis based on the FAERS database

ManTing Liu et al.

Article | Published online: 21 May 2024

Neurological disorders following the use of tumor necrosis factor-α inhibitors in inflammatory bowel disease patients: a real-world pharmacovigilance analysis

Yi Zhao et al.

Article | Published online: 21 May 2024

Safety assessment of clomiphene: a real-world pharmacovigilance analysis from the Food and Drug Administration adverse event reporting system

Yifeng Shao et al.

Article | Published online: 21 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.19, Iss.9, 2020)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?